DDR on DTC: Humira

Share this article:
Deborah Dick-Rath
Deborah Dick-Rath

Lately, Abbott has taken a leadership role in DTC, primarily for their multi-billion-dollar Humira franchise. They have marketed this monolithic brand with the power and expertise of a classic, gold-standard CPG or automotive brand, replete with multiple line extensions and satellite brands. The latest example of Humira's command of DTC brand marketing can be seen in the campaign for its Crohn's disease indication.

An effective educational/unbranded campaign was launched in July 2011 and ran until March 2012, whereupon the branded campaign took over. The unbranded campaign spoke to the anxiety that people with this disease have and encouraged a discussion with a gastroenterologist. Even though the commercials focused on the emotional anxiety of Crohn's, the ads offered hope and a potential solution.

Then, the branded campaign took up where the unbranded effort left off. The message shifted from the anxious “what if?” platform for untreated sufferers to reaching out to diagnosed patients to tell them that this brand can help resolve recurring symptoms and, importantly, share the news that “Remission is Possible.”

This advertising won't win a Cannes Lion for creativity. The website and surrounding tactics are fairly predictable. But what is fantastic about this campaign is the capacity that Abbott shows to be a brand steward for Humira. In the long run, that is sure to bring the greatest rewards to Abbott.

Deborah Dick-Rath is the President of Epic Proportions, a Healthcare Communications Consultancy. She can be reached at deborahdrath@optonline.net
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?